This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Milton Guran | |
|---|---|
| Name | Milton Guran |
| Birth date | 1950s |
| Birth place | Newark, New Jersey |
| Occupation | Psychiatrist, Researcher, Academic |
| Alma mater | Harvard University; Columbia University |
| Spouse | Maria Guran |
| Known for | Psychopharmacology, Bipolar disorder research, Academic leadership |
Milton Guran
Milton Guran is an American psychiatrist, psychopharmacologist, and academic leader noted for his work on bipolar disorder, mood stabilizers, and psychopharmacologic therapeutics. He has held senior faculty and administrative appointments at major medical centers and universities and contributed to clinical research, guideline development, and translational psychiatry. His career intersects clinical service, clinical trials, and medical education, involving collaborations with public health institutions, research consortia, and international organizations.
Guran was raised in Newark, New Jersey, and completed undergraduate studies at Harvard College before attending medical school at Columbia University Vagelos College of Physicians and Surgeons. He pursued residency training in psychiatry at Massachusetts General Hospital and a fellowship in psychopharmacology at McLean Hospital, affiliating with clinical programs connected to Harvard Medical School. His formative mentors included faculty from Johns Hopkins Hospital and researchers associated with the National Institute of Mental Health and the World Health Organization mental health initiatives.
Guran’s clinical and research career centers on mood disorders, psychopharmacology, and bipolar spectrum conditions, conducting randomized controlled trials and observational studies that influenced practice guidelines from bodies such as the American Psychiatric Association and the American Board of Psychiatry and Neurology. He led multi-site trials in collaboration with networks like the ClinicalTrials.gov registry and the National Institutes of Health clinical research programs. His work spans evaluation of anticonvulsant mood stabilizers, atypical antipsychotics, and adjunctive psychotropic agents, intersecting with regulatory review processes at the Food and Drug Administration.
He contributed to translational studies linking neuroimaging modalities—such as magnetic resonance imaging research groups at Massachusetts Institute of Technology and neurochemical assay collaborations with laboratories at Yale University—to clinical outcomes. Guran collaborated with international investigators in Europe and Asia, partnering with centers affiliated with the Royal College of Psychiatrists and the European College of Neuropsychopharmacology on cross-cultural studies of mood disorder epidemiology and treatment response.
Guran served in senior administrative roles at academic medical centers, including departmental leadership and clinical program directorships tied to large teaching hospitals such as Barnes-Jewish Hospital and university systems like Boston University and New York University. He participated in governance at academic consortia and was involved in strategic planning with organizations including the Association of American Medical Colleges and regional health networks. His administrative portfolio encompassed oversight of clinical services, research infrastructure, clinical trial units, and quality improvement initiatives in alignment with accreditation standards from the Joint Commission.
He represented psychiatric departments in institutional review boards and collaborated with grant-making agencies such as the National Science Foundation on interdisciplinary initiatives that bridged psychiatry, neuroscience, and informatics. Guran engaged with professional societies—the Society of Biological Psychiatry and the International Society for Bipolar Disorders—holding committee posts that shaped conference programs and guideline documents.
As a professor and clinical educator, Guran taught medical students, psychiatry residents, and fellows through clerkships and specialized seminars associated with institutions like Columbia University Irving Medical Center and Harvard Medical School. He directed fellowship programs in psychopharmacology and mentored junior faculty who later joined faculties at institutions such as Stanford University School of Medicine and University of California, San Francisco. His pedagogical activities included curriculum development for competency-based training modules and continuing medical education courses accredited by the American Medical Association and professional boards.
Guran supervised research trainees in grant-funded projects, helping mentees secure fellowships from organizations such as the K23 and collaborating with philanthropic foundations including the Graham Boeckh Foundation on trainee support and career development workshops.
Guran authored and coauthored numerous peer-reviewed articles in journals including the American Journal of Psychiatry, JAMA Psychiatry, and The Lancet Psychiatry, focusing on bipolar disorder outcomes, medication trials, and clinical practice algorithms. He contributed chapters to textbooks published by academic presses such as Oxford University Press and Cambridge University Press addressing mood stabilizer pharmacology and evidence-based management of affective disorders. His consensus statements and guideline contributions appeared in position papers endorsed by the World Federation of Societies of Biological Psychiatry and regional psychiatric associations.
He served on editorial boards for journals and edited special issues on mood disorders in collaboration with editors from Nature Reviews Neuroscience and specialty periodicals, and his trial methodology work informed standards used by the CONSORT group and clinical trial networks.
Guran received recognition from academic institutions and professional societies, including teaching awards at major medical schools and lifetime achievement citations from organizations such as the International Society for Bipolar Disorders and the Society of Biological Psychiatry. He held named fellowships and was an invited plenary speaker at conferences organized by the American Psychiatric Association and the European Psychiatric Association. Grant support for his research came from competitive awards administered by the National Institutes of Health and private foundations.
Guran resides in the northeastern United States with his spouse and has been active in mental health advocacy, partnering with nonprofit organizations such as NAMI and public education initiatives coordinated with municipal health departments and patient advocacy coalitions. He has participated in policy discussions with legislators and advisory panels addressing access to psychiatric care, stigma reduction campaigns, and integration of behavioral health services with primary care systems overseen by agencies like the Centers for Medicare & Medicaid Services.
Category:American psychiatrists Category:Psychopharmacologists Category:Living people